ATLAS / Macro Radar / Reporting / MGX

Metagenomi Therapeutics, Inc. (MGX) reporting calendar

Metagenomi Therapeutics, Inc. files periodic reports with the SEC as MGX on Nasdaq. Atlas tracks 10 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 29 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
10

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MGX market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-216774
10-K31 Dec 20255 Mar 202664 days0001193125-26-093976
10-Q30 Sep 202512 Nov 202543 days0001193125-25-276150
10-Q30 Jun 202512 Aug 202543 days0000950170-25-107308
10-Q31 Mar 202513 May 202543 days0000950170-25-070463
10-K31 Dec 202417 Mar 202576 days0000950170-25-040217
10-Q30 Sep 202413 Nov 202444 days0000950170-24-126273
10-Q30 Jun 202414 Aug 202445 days0000950170-24-096665
10-Q31 Mar 202414 May 202444 days0000950170-24-059504
10-K31 Dec 202327 Mar 202487 days0000950170-24-036838

Source: SEC EDGAR company submissions for CIK 0001785279. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.